MedPath

A study to evaluate the response of whole blood stimulation with lipopolysaccharide or other inducers and its in vitro inhibition in healthy volunteers, and patients with a chronic inflammatory conditio

Completed
Conditions
atherosclerose
rheumatoid arthritis
10011082
10003216
10003816
Registration Number
NL-OMON38316
Lead Sponsor
Centre for Human Drug Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
250
Inclusion Criteria

healthy males
healthy female volunteers: pre- and post-menopausal
patients with rheumatoid arthritis: active disease and with or without treatment with MTX
patients with Crohn's disease: clinically confirmed diagnosis of disease
patients with psoriasis: clinically confirmed diagnosis of disease, PASI score>5
patients with asthma: clinically confirmed diagnosis of disease
patients with proven atherosclerotic disease

Exclusion Criteria

general: any clinically significant disorder (current or past medical history or physical examination) that in the opinion of the investigator precludes study participation
patients: clinically significant abnormalities and recent treatment with anti-TNF therapy

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>activation markers of inflammation (cytokines, chemokines, etc)</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>n/a</p><br>
© Copyright 2025. All Rights Reserved by MedPath